New pain shot could cut opioid use after eye removal
NCT ID NCT02381353
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares a standard painkiller (bupivacaine) to a slow-release version (Exparel) for pain after eye removal surgery. 88 adults having their eye removed at Mayo Clinic will receive one of the two injections during surgery. The goal is to see if the slow-release drug provides better pain control for up to 3 days and reduces the need for oral narcotics.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN, POSTOPERATIVE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
-
University of Michigan Kellogg Eye Institute
Ann Arbor, Michigan, 48109, United States